Pantoprazol Altan (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Altan, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and Zollinger‑Ellison syndrome in adults. GNH USA supplies Pantoprazol Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Altan is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Erosive gastritis and duodenal ulcer disease: supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Pantoprazol Altan may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis. - Acute interstitial nephritis. - Low magnesium levels (hypomagnesemia). - Fracture risk with long‑term use. - Liver enzyme elevations.

When prescribing Pantoprazol Altan, consider the following safety measures: - Renal impairment: adjust monitoring if severe kidney disease is present. - Hepatic impairment: use with caution in patients with moderate to severe liver disease. - Long‑term therapy: evaluate need for periodic reassessment to avoid unnecessary prolonged exposure. - Concomitant medications: review for potential interactions, especially with drugs requiring gastric acidity for absorption. - Pregnancy and lactation: limit use to situations where benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Pantoprazol Altan can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption due to increased gastric pH. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR; monitor coagulation parameters. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: modest increase in serum concentration; assess clinical response. - Iron salts: decreased iron absorption; consider timing separation.